← 產業報告目錄

Endoscopic Ultrasonography (EUS) Market by Product (Endoscopes, Ultrasound Processors, Ultrasound Needles, Probes), Type (Diagnostic, Therapeutic), Application (Oncology, GI, End User (Hospitals, Ambulatory Surgical Center) - Global Forecast to 2029

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-02-25頁數 307報告編號 MD9316

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The endoscopic ultrasonography market is projected to reach USD 1.93 billion by 2029 from USD 1.37 billion in 2024, at a CAGR of 7.1% during the forecast period. The endoscopic ultrasonography market has had strong growth due to a number of factors such as the rising incidences of cancer, growing initiatives to develop healthcare infrastructure in underdeveloped regions, increasing preference for minimally invasive surgeries, and advancements in endoscopic procedures. “By product type, endoscopes segment is expected to account for the largest share in the endoscopic ultrasonography market.” The endoscopes segment accounted for the largest share of the endoscopic ultrasonography market in the forecast period. The increasing demand for minimally invasive procedures, coupled with advancements in technology enhancing precision and control, are significant drivers. Moreover, the rising prevalence of gastrointestinal disorders necessitates more efficient and accurate diagnostic and therapeutic procedures, further boosting the adoption of endoscopes. These factors collectively contribute to the growth potential for this segment within the market. “Diagnostics segment, by type is expected to have the largest market share in the endoscopic ultrasonography market” Based on type, the diagnostics segment is expected to dominate the endoscopic ultrasonography market due to the increasing demand for early and accurate detection of chronic diseases coupled with advancements in imaging technology, providing real-time visualization and high-resolution images. Moreover, rising adoption of EUS-guided fine needle aspiration procedures worldwide, driven by their minimally invasive nature and associated benefits like shorter recovery times and reduced post-operative complications have further boosted the growth in this segment, thereby indicating promising growth potential within the endoscopic ultrasonography market. “The gastrointestinal disorders segment accounted the second-largest market share in the endoscopic ultrasonography market.” By application, the gastrointestinal disorders segment accounted for the second-largest market share in the endoscopic ultrasonography market. This significant share can be attributed to the rising prevalence of gastrointestinal disorders such as gastric cancer, chronic pancreatitis, and pancreatic cancer. Moreover, the growing geriatric population which is more prone to gastrointestinal diseases increasingly demand for advanced diagnostic procedures. These factors’ all together play a significant role in propelling market growth. “Hospitals segment of the endoscopic ultrasonography market is expected to have largest share.” Based on end user, the hospitals segment of the endoscopic ultrasonography market is expected to hold the largest share during the forecast period owing to the factors like the availability of advanced infrastructure constituting broad range of advanced diagnostic and therapeutic techniques, coupled with skilled professionals like gastroenterologists and endoscopists. Moreover, hospitals serving as vital healthcare centers, continuously invest in innovative endoscopic ultrasonography devices to address evolving healthcare demands, thus propelling market growth. “Asia Pacific to hold third largest market share in the endoscopic ultrasonography market during the forecast period.” The Asia Pacific region accounted the third largest share in the endoscopic ultrasonography market in the forecast period. The growth is attributed to several factors, including the growing advanced healthcare infrastructure, widespread acceptance of innovative medical devices, and increasing healthcare expenditure in Asia Pacific region. Additionally, the ongoing enhancements in endoscopic technologies are anticipated to increase the demand for endoscopic ultrasonography devices in APAC region. A breakdown of the primary participants (supply side) for the endoscopic ultrasonography market referred to for this report is provided below: • By Company Type: Tier 1–35%, Tier 2–20%, and Tier 3–45% • By Designation: C-level–35%, Director Level- 45%, and Others–20% • By Region: North America–40%, Europe–30%, Asia Pacific–20%, Latin America-5%, and Middle East & Africa-5% Prominent players in the endoscopic ultrasonography market include Olympus Corporation (Japan), Medtronic (US), FUJIFILM Holdings Corporation (Japan), Boston Scientific Corporation (US), PENTAX Medical (Japan), Steris (Ireland), CONMED Corporation (US), Lepu Medical Technology(Beijing)Co., Ltd. (China), CANON MEDICAL SYSTEMS CORPORATION (Japan), Cook (US), Huaco Healthcare Technologies Co. Ltd.(China), SonoScape Medical Corp.(China), Endosound, Inc.(US), Limaca-Medical (Israel), Beijing ZKSK Technology Co., Ltd. (China), Kaigen Pharma Co., Ltd.(Japan), PIOLAX MEDICAL DEVICES, INC.(Japan), Micro-Tech Endoscopy (US), Shaili Endoscopy (India), Zhejiang Soudon Medical Technology Co., Ltd.(China), ENDO-FLEX GmbH. (Germany), Ace Medical Devices Pvt. Ltd. (India), Medi-Globe GmbH.(Arizona), Medorah Meditek Pvt. Ltd.(India), and InnerMedical Co., Ltd. (China). Research Coverage: The report analyzes the endoscopic ultrasonography market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, application, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall endoscopic ultrasonography market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. This report provides insights into the following pointers: • Analysis of key drivers (increasing requirement for endoscopy procedures to diagnose and treat target diseases, rising incidence of gastrointestinal disorders and colorectal cancer, increased investments, funds, and grants by government bodies and other organizations, technological advancements in endoscopic ultrasonography devices), restraints (high costs of endoscopic ultrasonography procedures, and complications and limitations of endoscopic ultrasonography), opportunities (high market growth potential in emerging economies, and increasing preference for minimally invasive surgeries) and challenges (increasing number of product recalls). • Market Penetration: It includes extensive information on products offered by the major players in the global the endoscopic ultrasonography market. The report includes various segments in product, type, application, end user and region. • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global endoscopic ultrasonography market. • Market Development: Thorough knowledge and analysis of the profitable rising markets by product, type, application, end user and region. • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the endoscopic ultrasonography market. • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global endoscopic ultrasonography market.
目錄 Table of Contents
1 INTRODUCTION 29 1.1 STUDY OBJECTIVES 29 1.2 MARKET DEFINITION 29 1.3 STUDY SCOPE 30 1.3.1 MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD 30 1.3.2 INCLUSIONS & EXCLUSIONS 31 1.3.3 YEARS CONSIDERED 31 1.3.4 CURRENCY CONSIDERED 32 1.4 STAKEHOLDERS 32 2 RESEARCH METHODOLOGY 33 2.1 RESEARCH DATA 33 2.1.1 SECONDARY DATA 34 2.1.1.1 Key sources of secondary data 34 2.1.1.2 Key data from secondary sources 35 2.1.2 PRIMARY DATA 36 2.1.2.1 Key primary sources 36 2.1.2.2 Key objectives of primary research 37 2.1.2.3 Key data from primary sources 37 2.1.2.4 Key primary insights 38 2.2 MARKET SIZE ESTIMATION 40 2.2.1 BOTTOM-UP APPROACH 40 2.2.2 TOP-DOWN APPROACH 41 2.2.3 DEMAND-SIDE APPROACH 42 2.2.4 VOLUME DATA ANALYSIS 43 2.2.5 PROCEDURE DATA ANALYSIS 43 2.3 DATA TRIANGULATION 46 2.4 MARKET SHARE ANALYSIS 47 2.5 STUDY ASSUMPTIONS 47 2.6 RESEARCH LIMITATIONS 48 2.7 RISK ASSESSMENT 48 3 EXECUTIVE SUMMARY 49 4 PREMIUM INSIGHTS 53 4.1 ENDOSCOPIC ULTRASOUND MARKET OVERVIEW 53 4.2 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY END USER AND COUNTRY, 2023 54 4.3 ENDOSCOPIC ULTRASOUND MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55 4.4 ENDOSCOPIC ULTRASOUND MARKET: REGIONAL MIX 56 4.5 ENDOSCOPIC ULTRASOUND MARKET: DEVELOPED VS. EMERGING ECONOMIES 56 5 MARKET OVERVIEW 57 5.1 INTRODUCTION 57 5.2 MARKET DYNAMICS 57 5.2.1 DRIVERS 58 5.2.1.1 Increasing requirement for endoscopy procedures to diagnose and treat target diseases 58 5.2.1.2 Rising incidence of gastrointestinal disorders and colorectal cancer 59 5.2.1.3 Increased investments, funds, and grants by government bodies and other organizations 60 5.2.1.4 Technological advancements in endoscopic ultrasound devices 61 5.2.2 RESTRAINTS 62 5.2.2.1 High costs of endoscopic ultrasound procedures 62 5.2.2.2 Complications and limitations of endoscopic ultrasound 64 5.2.3 OPPORTUNITIES 64 5.2.3.1 High market growth potential in emerging economies 64 5.2.3.2 Increasing preference for minimally invasive surgeries 65 5.2.4 CHALLENGES 66 5.2.4.1 Increasing number of product recalls 66 5.3 INDUSTRY TRENDS 66 5.3.1 ULTRASOUND CAPSULE ENDOSCOPY 66 5.3.2 ENDOSCOPIC ULTRASOUND-GUIDED SHEAR WAVE ELASTOGRAPHY 67 5.4 VALUE CHAIN ANALYSIS 67 5.5 SUPPLY CHAIN ANALYSIS 68 5.6 TECHNOLOGY ANALYSIS 70 5.6.1 KEY TECHNOLOGIES 70 5.6.1.1 Contrast-enhanced endoscopic ultrasound 70 5.6.1.2 Lumen-apposing metal stents 70 5.6.2 COMPLEMENTARY TECHNOLOGIES 71 5.6.2.1 Elastography 71 5.7 PORTER’S FIVE FORCES ANALYSIS 71 5.7.1 THREAT OF NEW ENTRANTS 72 5.7.2 THREAT OF SUBSTITUTES 72 5.7.3 BARGAINING POWER OF SUPPLIERS 72 5.7.4 BARGAINING POWER OF BUYERS 73 5.7.5 INTENSITY OF COMPETITIVE RIVALRY 73 5.8 KEY STAKEHOLDERS & BUYING CRITERIA 73 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 73 5.8.2 KEY BUYING CRITERIA 74   5.9 REGULATORY ANALYSIS 74 5.9.1 REGULATORY FRAMEWORK 75 5.9.1.1 North America 75 5.9.1.1.1 US 75 5.9.1.1.2 Canada 75 5.9.1.2 Europe 75 5.9.1.2.1 Germany 76 5.9.1.2.2 France 76 5.9.1.2.3 UK 76 5.9.1.2.4 Italy 77 5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 5.10 PRICING ANALYSIS 79 5.10.1 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY KEY PLAYER, 2021–2023 79 5.10.2 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY REGION, 2021–2023 81 5.11 ECOSYSTEM ANALYSIS 82 5.11.1 ROLE IN ECOSYSTEM 83 5.12 PATENT ANALYSIS 84 5.12.1 PATENT PUBLICATION TRENDS FOR ENDOSCOPIC ULTRASOUND 84 5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 85 5.13 TRADE ANALYSIS 87 5.13.1 IMPORT DATA FOR HS CODE 901890 87 5.13.2 EXPORT DATA FOR HS CODE 901890 88 5.14 KEY CONFERENCES & EVENTS, 2025–2026 88 5.15 UNMET NEEDS/END-USER EXPECTATIONS 90 5.16 IMPACT OF AI/GEN AI ON ENDOSCOPIC ULTRASOUND MARKET 91 5.17 CASE STUDY ANALYSIS 92 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 93 5.19 ADJACENT MARKETS 94 5.20 INVESTMENT & FUNDING SCENARIO 94 6 ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT 95 6.1 INTRODUCTION 96 6.2 ENDOSCOPES 96 6.2.1 RADIAL ENDOSCOPES 98 6.2.1.1 High image quality, improved penetration depth, and excellent maneuverability to propel segment growth 98 6.2.2 LINEAR ENDOSCOPES 99 6.2.2.1 Improved real-time targeting of lesions and better clinical management to aid segment growth 99   6.3 ULTRASOUND PROCESSORS 101 6.3.1 ULTRASOUND PROCESSORS TO PRECISELY DETECT ABNORMALITIES AND FACILITATE BETTER TREATMENT PLANNING 101 6.4 ULTRASOUND PROBES 103 6.4.1 CONSTANT INNOVATIONS AND ADVANCEMENTS TO AUGMENT MARKET GROWTH 103 6.5 ULTRASOUND NEEDLES 104 6.5.1 FINE NEEDLE ASPIRATION 106 6.5.1.1 Superior accuracy and effectiveness in staging cancer to fuel segment growth 106 6.5.2 FINE NEEDLE BIOPSIES 107 6.5.2.1 Improved diagnostic accuracy in pancreatic and non-pancreatic lesions to boost segment growth 107 6.5.3 OTHER ULTRASOUND NEEDLES 108 6.6 ACCESSORIES 109 6.6.1 INCREASING ADOPTION OF ACCESSORIES FOR BETTER EFFICIENCY, PRECISION, AND SAFETY OF PROCEDURES TO DRIVE MARKET 109 7 ENDOSCOPIC ULTRASOUND MARKET, BY TYPE 111 7.1 INTRODUCTION 112 7.2 DIAGNOSTICS 112 7.2.1 RISING PREVALENCE OF GASTROINTESTINAL DISEASES TO PROPEL MARKET GROWTH 112 7.3 THERAPEUTICS 113 7.3.1 INCREASING ADOPTION OF MINIMALLY INVASIVE PROCEDURES FOR PANCREATIC DISORDERS TO AID SEGMENT GROWTH 113 8 ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION 115 8.1 INTRODUCTION 116 8.2 ONCOLOGY 116 8.2.1 UPPER GASTROINTESTINAL ONCOLOGY 118 8.2.1.1 Increasing incidence of esophageal and gastric cancers to drive segment 118 8.2.2 LOWER GASTROINTESTINAL ONCOLOGY 119 8.2.2.1 High prevalence of colorectal cancer to support segment growth 119 8.3 GASTROINTESTINAL DISORDERS 120 8.3.1 PANCREATIC DISORDERS 122 8.3.1.1 Rising burden of chronic pancreatic diseases to aid segment growth 122 8.3.2 OTHER GASTROINTESTINAL DISORDERS 124 8.4 OTHER APPLICATIONS 125   9 ENDOSCOPIC ULTRASOUND MARKET, BY END USER 127 9.1 INTRODUCTION 128 9.2 HOSPITALS 128 9.2.1 INCREASED DEMAND FOR ADVANCED IMAGING TECHNIQUES AND PRECISE DIAGNOSTICS TO SPUR MARKET GROWTH 128 9.3 AMBULATORY SURGERY CENTERS 129 9.3.1 COST-EFFECTIVENESS AND HIGH REIMBURSEMENT RATES TO PROPEL MARKET GROWTH 129 9.4 OTHER END USERS 131 10 ENDOSCOPIC ULTRASOUND MARKET, BY REGION 133 10.1 INTRODUCTION 134 10.2 NORTH AMERICA 135 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 136 10.2.2 US 140 10.2.2.1 US to dominate North American endoscopic ultrasound market during forecast period 140 10.2.3 CANADA 144 10.2.3.1 Rising incidence of cancer and increasing focus on early disease detection to propel market growth 144 10.3 EUROPE 148 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 148 10.3.2 GERMANY 151 10.3.2.1 Increased healthcare spending and favorable research initiatives to spur market growth 151 10.3.3 UK 155 10.3.3.1 High government healthcare funding to support market growth 155 10.3.4 FRANCE 158 10.3.4.1 Advancements in healthcare and favorable national health insurance to fuel market growth 158 10.3.5 ITALY 161 10.3.5.1 Rising geriatric population and increasing focus on cancer care to propel market growth 161 10.3.6 SPAIN 165 10.3.6.1 High prevalence of lifestyle-related cancer risk and increased healthcare expenditure to augment market growth 165 10.3.7 REST OF EUROPE 168 10.4 ASIA PACIFIC 171 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 171 10.4.2 JAPAN 176 10.4.2.1 Favorable government health insurance schemes and high geriatric population to aid market growth 176 10.4.3 CHINA 179 10.4.3.1 Large patient pool and high obesity rates to drive market 179 10.4.4 INDIA 183 10.4.4.1 Increasing prevalence of cancer and improved government healthcare initiatives to aid market growth 183 10.4.5 SOUTH KOREA 186 10.4.5.1 High incidence of gastrointestinal diseases and cancer among aged population to fuel market growth 186 10.4.6 AUSTRALIA 190 10.4.6.1 Increased patient volume and favorable government initiatives to drive market 190 10.4.7 REST OF ASIA PACIFIC 193 10.5 LATIN AMERICA 196 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 196 10.5.2 BRAZIL 200 10.5.2.1 High risk of chronic diseases among geriatric population to propel market growth 200 10.5.3 MEXICO 203 10.5.3.1 Improved healthcare infrastructure and increased cancer awareness to augment market growth 203 10.5.4 REST OF LATIN AMERICA 207 10.6 MIDDLE EAST & AFRICA 210 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 210 10.6.2 GCC COUNTRIES 214 10.6.2.1 Increasing healthcare infrastructure development and investment to support market growth 214 10.6.3 REST OF MIDDLE EAST AND AFRICA 217 11 COMPETITIVE LANDSCAPE 221 11.1 INTRODUCTION 221 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 221 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENDOSCOPIC ULTRASOUND MARKET 221 11.3 REVENUE ANALYSIS, 2019–2023 223 11.4 MARKET SHARE ANALYSIS, 2023 224 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 226 11.5.1 STARS 226 11.5.2 EMERGING LEADERS 226 11.5.3 PERVASIVE PLAYERS 226 11.5.4 PARTICIPANTS 226 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 228 11.5.5.1 Company footprint 228 11.5.5.2 Region footprint 229 11.5.5.3 Product footprint 230 11.5.5.4 Type footprint 232 11.5.5.5 Application footprint 233 11.5.5.6 End-user footprint 234 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 235 11.6.1 PROGRESSIVE COMPANIES 235 11.6.2 RESPONSIVE COMPANIES 235 11.6.3 DYNAMIC COMPANIES 235 11.6.4 STARTING BLOCKS 235 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 237 11.6.5.1 Detailed list of key startups/SMEs 237 11.6.5.2 Competitive benchmarking of key startups/SMEs 238 11.7 COMPANY VALUATION & FINANCIAL METRICS 239 11.8 BRAND/PRODUCT COMPARISON 240 11.9 R&D ASSESSMENT OF KEY PLAYERS 241 11.10 COMPETITIVE SCENARIO 242 11.10.1 PRODUCT LAUNCHES & APPROVALS 242 11.10.2 EXPANSIONS 243 11.10.3 DEALS 244 11.10.4 OTHER DEVELOPMENTS 245 12 COMPANY PROFILES 246 12.1 KEY PLAYERS 246 12.1.1 OLYMPUS CORPORATION 246 12.1.1.1 Business overview 246 12.1.1.2 Products offered 248 12.1.1.3 Recent developments 249 12.1.1.3.1 Product launches & approvals 249 12.1.1.3.2 Deals 250 12.1.1.3.3 Expansions 251 12.1.1.4 MnM view 252 12.1.1.4.1 Key strengths 252 12.1.1.4.2 Strategic choices 252 12.1.1.4.3 Weaknesses & competitive threats 252 12.1.2 MEDTRONIC 253 12.1.2.1 Business overview 253 12.1.2.2 Products offered 254 12.1.2.3 Recent developments 255 12.1.2.3.1 Product approvals 255 12.1.2.3.2 Deals 255 12.1.2.3.3 Expansions 256 12.1.2.4 MnM view 256 12.1.2.4.1 Key strengths 256 12.1.2.4.2 Strategic choices 256 12.1.2.4.3 Weaknesses & competitive threats 256 12.1.3 FUJIFILM HOLDINGS CORPORATION 257 12.1.3.1 Business overview 257 12.1.3.2 Products offered 259 12.1.3.3 Recent developments 260 12.1.3.3.1 Product launches & approvals 260 12.1.3.3.2 Deals 261 12.1.3.3.3 Other developments 261 12.1.3.4 MnM view 262 12.1.3.4.1 Key strengths 262 12.1.3.4.2 Strategic choices 262 12.1.3.4.3 Weaknesses & competitive threats 262 12.1.4 BOSTON SCIENTIFIC CORPORATION 263 12.1.4.1 Business overview 263 12.1.4.2 Products offered 264 12.1.4.3 Recent developments 265 12.1.4.3.1 Product approvals 265 12.1.4.3.2 Deals 265 12.1.4.4 MnM view 266 12.1.4.4.1 Key strengths 266 12.1.4.4.2 Strategic choices 266 12.1.4.4.3 Weaknesses & competitive threats 266 12.1.5 PENTAX MEDICAL 267 12.1.5.1 Business overview 267 12.1.5.2 Products offered 267 12.1.5.3 Recent developments 269 12.1.5.3.1 Product launches & approvals 269 12.1.5.3.2 Deals 270 12.1.5.4 MnM view 270 12.1.5.4.1 Key strengths 270 12.1.5.4.2 Strategic choices 270 12.1.5.4.3 Weaknesses & competitive threats 270 12.1.6 STERIS 271 12.1.6.1 Business overview 271 12.1.6.2 Products offered 273 12.1.6.3 Recent developments 273 12.1.6.3.1 Deals 273 12.1.6.3.2 Expansions 274 12.1.7 CONMED CORPORATION 275 12.1.7.1 Business overview 275 12.1.7.2 Products offered 276 12.1.7.3 Recent developments 277 12.1.7.3.1 Deals 277 12.1.8 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 278 12.1.8.1 Business overview 278 12.1.8.2 Products offered 279 12.1.8.3 Recent developments 279 12.1.8.3.1 Product approvals 279 12.1.9 CANON MEDICAL SYSTEMS CORPORATION 280 12.1.9.1 Business overview 280 12.1.9.2 Products offered 281 12.1.9.3 Recent developments 282 12.1.9.3.1 Deals 282 12.1.10 COOK 283 12.1.10.1 Business overview 283 12.1.10.2 Products offered 283 12.1.10.3 Recent developments 284 12.1.10.3.1 Product launches 284 12.1.10.3.2 Deals 284 12.1.10.3.3 Expansions 285 12.2 OTHER PLAYERS 286 12.2.1 HUACO HEALTHCARE TECHNOLOGIES CO., LTD. 286 12.2.2 SONOSCAPE MEDICAL CORP. 287 12.2.3 ENDOSOUND, INC. 288 12.2.4 LIMACA-MEDICAL 288 12.2.5 BEIJING ZKSK TECHNOLOGY CO., LTD. 289 12.2.6 KAIGEN PHARMA CO., LTD. 290 12.2.7 PIOLAX MEDICAL DEVICES, INC. 291 12.2.8 MICRO-TECH ENDOSCOPY 291 12.2.9 SHAILI ENDOSCOPY 292 12.2.10 ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO., LTD. 293 12.2.11 ENDO-FLEX GMBH 294 12.2.12 ACE MEDICAL DEVICES PVT. LTD. 295 12.2.13 MEDI-GLOBE GMBH 295 12.2.14 MEDORAH MEDITEK PVT. LTD. 296 12.2.15 INNERMEDICAL CO., LTD. 297 13 APPENDIX 298 13.1 DISCUSSION GUIDE 298 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 303 13.3 CUSTOMIZATION OPTIONS 305 13.4 RELATED REPORTS 305 13.5 AUTHOR DETAILS 306
圖表清單 List of Tables & Figures
TABLE 1 ENDOSCOPIC ULTRASOUND MARKET: INCLUSIONS & EXCLUSIONS 31 TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD) 32 TABLE 3 ENDOSCOPIC ULTRASOUND MARKET: STUDY ASSUMPTIONS 47 TABLE 4 ENDOSCOPIC ULTRASOUND MARKET: RISK ASSESSMENT 48 TABLE 5 US: ESTIMATED NUMBER OF NEW COLORECTAL CANCER CASES, BY AGE AND SEX (2023) 60 TABLE 6 MAJOR DEVELOPMENTS IN FUNDING ORGANIZATIONS, JANUARY 2021–DECEMBER 2024 60 TABLE 7 GENERIC DIAGNOSTIC ENDOSCOPIC ULTRASOUND PROCEDURE COST IN ALBERTA, CANADA (2023) 62 TABLE 8 COST OF RECTAL ENDOSCOPIC ULTRASOUND FOR US (2023) 62 TABLE 9 COMPANY EXPANSIONS IN EMERGING ECONOMIES 65 TABLE 10 LIST OF PRODUCT RECALLS BY KEY PLAYERS, 2020–2022 66 TABLE 11 ENDOSCOPIC ULTRASOUND MARKET: PORTER’S FIVE FORCES 72 TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 73 TABLE 13 KEY BUYING CRITERIA FOR TOP THREE END USERS 74 TABLE 14 REGULATORY STANDARDS/APPROVALS REQUIRED FOR ENDOSCOPY, BY COUNTRY 77 TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 18 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY KEY PLAYER, 2021–2023 79 TABLE 19 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY REGION, 2021–2023 81 TABLE 20 ENDOSCOPIC ULTRASOUND MARKET: ROLE IN ECOSYSTEM 83 TABLE 21 ENDOSCOPIC ULTRASOUND MARKET: LIST OF PATENTS/PATENT APPLICATIONS, JANUARY 2021–DECEMBER 2024 86 TABLE 22 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019–2023 (USD THOUSAND) 87 TABLE 23 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019–2023 (USD THOUSAND) 88 TABLE 24 ENDOSCOPIC ULTRASOUND MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 88 TABLE 25 ENDOSCOPIC ULTRASOUND MARKET: UNMET NEEDS/END-USER EXPECTATIONS 90 TABLE 26 DEVELOPMENT OF ADVANCED SYSTEMS BY OLYMPUS CORPORATION TO ENHANCE MANAGEMENT OF GASTROINTESTINAL AND PANCREATICOBILIARY DISEASES 92 TABLE 27 USE OF SLIM LINEAR ECHOENDOSCOPE IN EUS PROCEDURES BY PENTAX MEDICAL 92 TABLE 28 USE OF SHARKCORE FNB NEEDLE BY MEDTRONIC TO FACILITATE DIAGNOSTIC YIELD IN EUS-GUIDED BIOPSIES 93 TABLE 29 ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 96 TABLE 30 ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION) 97 TABLE 31 ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 98 TABLE 32 RADIAL ENDOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 99 TABLE 33 LINEAR ENDOSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 100 TABLE 34 ENDOSCOPIC ULTRASOUND PROCESSORS MARKET, BY REGION, 2022–2029 (THOUSAND UNITS) 101 TABLE 35 ENDOSCOPIC ULTRASOUND PROCESSORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 102 TABLE 36 ENDOSCOPIC ULTRASOUND PROBES MARKET, BY REGION, 2022–2029 (THOUSAND UNITS) 103 TABLE 37 ENDOSCOPIC ULTRASOUND PROBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 104 TABLE 38 ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 105 TABLE 39 ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 105 TABLE 40 FINE NEEDLE ASPIRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 106 TABLE 41 FINE NEEDLE BIOPSIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 107 TABLE 42 OTHER ULTRASOUND NEEDLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 109 TABLE 43 ENDOSCOPIC ULTRASOUND MARKET FOR ACCESSORIES, BY COUNTRY, 2022–2029 (USD MILLION) 110 TABLE 44 ENDOSCOPIC ULTRASOUND MARKET, BY TYPE 2022–2029 (USD MILLION) 112 TABLE 45 ENDOSCOPIC ULTRASOUND MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 113 TABLE 46 ENDOSCOPIC ULTRASOUND MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION) 114 TABLE 47 ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION 2022–2029 (USD MILLION) 116 TABLE 48 ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 117 TABLE 49 ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 118 TABLE 50 UPPER GASTROINTESTINAL ONCOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 119 TABLE 51 LOWER GASTROINTESTINAL ONCOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 120 TABLE 52 ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 121 TABLE 53 NUMBER OF PROCEDURES FOR GASTROINTESTINAL DISORDERS, BY REGION, 2023 (THOUSAND/MILLION) 121 TABLE 54 ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 122 TABLE 55 PANCREATIC DISORDERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123 TABLE 56 OTHER GASTROINTESTINAL DISORDERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125 TABLE 57 ENDOSCOPIC ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 126 TABLE 58 ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 128 TABLE 59 ENDOSCOPIC ULTRASOUND MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION) 129 TABLE 60 ENDOSCOPIC ULTRASOUND MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 130 TABLE 61 ENDOSCOPIC ULTRASOUND MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 132 TABLE 62 ENDOSCOPIC ULTRASOUND MARKET, BY REGION, 2022–2029 (USD MILLION) 135 TABLE 63 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137 TABLE 64 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 137 TABLE 65 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 137 TABLE 66 NORTH AMERICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 138 TABLE 67 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 138 TABLE 68 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 138 TABLE 69 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 139 TABLE 70 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 139 TABLE 71 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 139 TABLE 72 MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2024 140 TABLE 73 US: KEY MACROINDICATORS 141 TABLE 74 US: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 141 TABLE 75 US: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 141 TABLE 76 US: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 142 TABLE 77 US: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 142 TABLE 78 US: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 142 TABLE 79 US: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 143 TABLE 80 US: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 143 TABLE 81 US: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 143 TABLE 82 CANADA: KEY MACROINDICATORS 145 TABLE 83 CANADA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 145 TABLE 84 CANADA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 145 TABLE 85 CANADA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 146 TABLE 86 CANADA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 146 TABLE 87 CANADA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 146 TABLE 88 CANADA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 147 TABLE 89 CANADA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 147 TABLE 90 CANADA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 147 TABLE 91 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 148 TABLE 92 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 149 TABLE 93 EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 149 TABLE 94 EUROPE: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 149 TABLE 95 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 150 TABLE 96 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 150 TABLE 97 EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 150 TABLE 98 EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 151 TABLE 99 EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 151 TABLE 100 GERMANY: KEY MACROINDICATORS 152 TABLE 101 GERMANY: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 152 TABLE 102 GERMANY: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 152 TABLE 103 GERMANY: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 153 TABLE 104 GERMANY: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 153 TABLE 105 GERMANY: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 153 TABLE 106 GERMANY: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 154 TABLE 107 GERMANY: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 154 TABLE 108 GERMANY: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 154 TABLE 109 UK: KEY MACROINDICATORS 155 TABLE 110 UK: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 155 TABLE 111 UK: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 156 TABLE 112 UK: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 156 TABLE 113 UK: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 156 TABLE 114 UK: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 157 TABLE 115 UK: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 157 TABLE 116 UK: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 157 TABLE 117 UK: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 158 TABLE 118 FRANCE: KEY MACROINDICATORS 158 TABLE 119 FRANCE: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 159 TABLE 120 FRANCE: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 159 TABLE 121 FRANCE: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 159 TABLE 122 FRANCE: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 160 TABLE 123 FRANCE: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 160 TABLE 124 FRANCE: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 160 TABLE 125 FRANCE: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 161 TABLE 126 FRANCE: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 161 TABLE 127 ITALY: KEY MACROINDICATORS 162 TABLE 128 ITALY: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 162 TABLE 129 ITALY: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 162 TABLE 130 ITALY: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 163 TABLE 131 ITALY: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 163 TABLE 132 ITALY: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 163 TABLE 133 ITALY: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 164 TABLE 134 ITALY: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 164 TABLE 135 ITALY: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 164 TABLE 136 SPAIN: KEY MACROINDICATORS 165 TABLE 137 SPAIN: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 165 TABLE 138 SPAIN: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 166 TABLE 139 SPAIN: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 166 TABLE 140 SPAIN: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 166 TABLE 141 SPAIN: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 167 TABLE 142 SPAIN: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 167 TABLE 143 SPAIN: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 167 TABLE 144 SPAIN: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 168 TABLE 145 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 168 TABLE 146 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 169 TABLE 147 REST OF EUROPE: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 169 TABLE 148 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 169 TABLE 149 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 170 TABLE 150 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 170 TABLE 151 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 170 TABLE 152 REST OF EUROPE: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 171 TABLE 153 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173 TABLE 154 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 173 TABLE 155 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 173 TABLE 156 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 174 TABLE 157 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 174 TABLE 158 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 174 TABLE 159 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 175 TABLE 160 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 175 TABLE 161 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 175 TABLE 162 JAPAN: KEY MACROINDICATORS 176 TABLE 163 JAPAN: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 177 TABLE 164 JAPAN: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 177 TABLE 165 JAPAN: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 177 TABLE 166 JAPAN: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 178 TABLE 167 JAPAN: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 178 TABLE 168 JAPAN: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 178 TABLE 169 JAPAN: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 179 TABLE 170 JAPAN: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 179 TABLE 171 CHINA: KEY MACROINDICATORS 180 TABLE 172 CHINA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 180 TABLE 173 CHINA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 180 TABLE 174 CHINA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 181 TABLE 175 CHINA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 181 TABLE 176 CHINA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 181 TABLE 177 CHINA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 182 TABLE 178 CHINA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 182 TABLE 179 CHINA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 182 TABLE 180 INDIA: KEY MACROINDICATORS 183 TABLE 181 INDIA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 184 TABLE 182 INDIA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 184 TABLE 183 INDIA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 184 TABLE 184 INDIA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 185 TABLE 185 INDIA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 185 TABLE 186 INDIA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 185 TABLE 187 INDIA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 186 TABLE 188 INDIA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 186 TABLE 189 SOUTH KOREA: KEY MACROINDICATORS 187 TABLE 190 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 187 TABLE 191 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 187 TABLE 192 SOUTH KOREA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 188 TABLE 193 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 188 TABLE 194 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 188 TABLE 195 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 189 TABLE 196 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 189 TABLE 197 SOUTH KOREA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 189 TABLE 198 AUSTRALIA: KEY MACROINDICATORS 190 TABLE 199 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 190 TABLE 200 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 191 TABLE 201 AUSTRALIA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 191 TABLE 202 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 191 TABLE 203 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 192 TABLE 204 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 192 TABLE 205 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 192 TABLE 206 AUSTRALIA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 193 TABLE 207 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 193 TABLE 208 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 194 TABLE 209 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194 TABLE 210 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 194 TABLE 211 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 195 TABLE 212 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 195 TABLE 213 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 195 TABLE 214 REST OF ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 196 TABLE 215 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 197 TABLE 216 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 197 TABLE 217 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 197 TABLE 218 LATIN AMERICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 198 TABLE 219 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 198 TABLE 220 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 198 TABLE 221 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 199 TABLE 222 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 199 TABLE 223 LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 199 TABLE 224 BRAZIL: KEY MACROINDICATORS 200 TABLE 225 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 201 TABLE 226 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 201 TABLE 227 BRAZIL: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 201 TABLE 228 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 202 TABLE 229 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 202 TABLE 230 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 202 TABLE 231 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 203 TABLE 232 BRAZIL: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 203 TABLE 233 MEXICO: KEY MACROINDICATORS 204 TABLE 234 MEXICO: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 204 TABLE 235 MEXICO: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 204 TABLE 236 MEXICO: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 205 TABLE 237 MEXICO: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 205 TABLE 238 MEXICO: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 205 TABLE 239 MEXICO: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 206 TABLE 240 MEXICO: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 206 TABLE 241 MEXICO: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 206 TABLE 242 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 207 TABLE 243 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 207 TABLE 244 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 208 TABLE 245 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 208 TABLE 246 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 208 TABLE 247 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 209 TABLE 248 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 209 TABLE 249 REST OF LATIN AMERICA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 209 TABLE 250 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY REGION, 2022–2029 (USD MILLION) 211 TABLE 251 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 211 TABLE 252 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 211 TABLE 253 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 212 TABLE 254 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 212 TABLE 255 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 212 TABLE 256 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 213 TABLE 257 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 213 TABLE 258 MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 213 TABLE 259 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 214 TABLE 260 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 215 TABLE 261 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 215 TABLE 262 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 215 TABLE 263 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 216 TABLE 264 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 216 TABLE 265 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 216 TABLE 266 GCC COUNTRIES: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 217 TABLE 267 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 218 TABLE 268 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR ENDOSCOPES, BY TYPE, 2022–2029 (USD MILLION) 218 TABLE 269 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND NEEDLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 218 TABLE 270 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2022–2029 (USD MILLION) 219 TABLE 271 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 219 TABLE 272 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 219 TABLE 273 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET FOR GASTROINTESTINAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 220 TABLE 274 REST OF MIDDLE EAST & AFRICA: ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2022–2029 (USD MILLION) 220 TABLE 275 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ENDOSCOPIC ULTRASOUND MARKET 221 TABLE 276 ENDOSCOPIC ULTRASOUND MARKET: DEGREE OF COMPETITION 225 TABLE 277 ENDOSCOPIC ULTRASOUND MARKET: REGION FOOTPRINT 229 TABLE 278 ENDOSCOPIC ULTRASOUND MARKET: PRODUCT FOOTPRINT 230 TABLE 279 ENDOSCOPIC ULTRASOUND MARKET: TYPE FOOTPRINT 232 TABLE 280 ENDOSCOPIC ULTRASOUND MARKET: APPLICATION FOOTPRINT 233 TABLE 281 ENDOSCOPIC ULTRASOUND MARKET: END-USER FOOTPRINT 234 TABLE 282 ENDOSCOPIC ULTRASOUND MARKET: DETAILED LIST OF KEY STARTUPS/SMES 237 TABLE 283 ENDOSCOPIC ULTRASOUND MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 238 TABLE 284 ENDOSCOPIC ULTRASOUND MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024 242 TABLE 285 ENDOSCOPIC ULTRASOUND MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2024 243 TABLE 286 ENDOSCOPIC ULTRASOUND MARKET: DEALS, JANUARY 2021–DECEMBER 2024 244 TABLE 288 OLYMPUS CORPORATION: COMPANY OVERVIEW 246 TABLE 289 OLYMPUS CORPORATION: PRODUCTS OFFERED 248 TABLE 290 OLYMPUS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024 249 TABLE 291 OLYMPUS CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024 250 TABLE 292 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2021–DECEMBER 2024 251 TABLE 293 MEDTRONIC: COMPANY OVERVIEW 253 TABLE 294 MEDTRONIC: PRODUCTS OFFERED 254 TABLE 295 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2024 255 TABLE 296 MEDTRONIC: DEALS, JANUARY 2021–DECEMBER 2024 255 TABLE 297 MEDTRONIC: EXPANSIONS, JANUARY 2021–DECEMBER 2024 256 TABLE 298 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 257 TABLE 299 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED 259 TABLE 300 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024 260 TABLE 301 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024 261 TABLE 302 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024 261 TABLE 303 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 263 TABLE 304 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 264 TABLE 305 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2024 265 TABLE 306 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024 265 TABLE 307 PENTAX MEDICAL: COMPANY OVERVIEW 267 TABLE 308 PENTAX MEDICAL: PRODUCTS OFFERED 267 TABLE 309 PENTAX MEDICAL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024 269   TABLE 310 PENTAX MEDICAL: DEALS, JANUARY 2021−DECEMBER 2024 270 TABLE 311 STERIS: COMPANY OVERVIEW 271 TABLE 312 STERIS: PRODUCTS OFFERED 273 TABLE 313 STERIS: DEALS, JANUARY 2021–DECEMBER 2024 273 TABLE 314 STERIS: EXPANSIONS, JANUARY 2021–DECEMBER 2024 274 TABLE 315 CONMED CORPORATION: COMPANY OVERVIEW 275 TABLE 316 CONMED CORPORATION: PRODUCTS OFFERED 276 TABLE 317 CONMED CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024 277 TABLE 318 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW 278 TABLE 319 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCTS OFFERED 279 TABLE 320 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2024 279 TABLE 321 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 280 TABLE 322 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 281 TABLE 323 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024 282 TABLE 324 COOK: COMPANY OVERVIEW 283 TABLE 325 COOK: PRODUCTS OFFERED 283 TABLE 326 COOK: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024 284 TABLE 327 COOK: DEALS, JANUARY 2021–DECEMBER 2024 284 TABLE 328 COOK: EXPANSIONS, JANUARY 2021–DECEMBER 2024 285 TABLE 329 HUACO HEALTHCARE TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 286 TABLE 330 SONOSCAPE MEDICAL CORP.: COMPANY OVERVIEW 287 TABLE 331 ENDOSOUND, INC.: COMPANY OVERVIEW 288 TABLE 332 LIMACA-MEDICAL: COMPANY OVERVIEW 288 TABLE 333 BEIJING ZKSK TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 289 TABLE 334 KAIGEN PHARMA CO., LTD.: COMPANY OVERVIEW 290 TABLE 335 PIOLAX MEDICAL DEVICES, INC.: COMPANY OVERVIEW 291 TABLE 336 MICRO-TECH ENDOSCOPY: COMPANY OVERVIEW 291 TABLE 337 SHAILI ENDOSCOPY: COMPANY OVERVIEW 292 TABLE 338 ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 293 TABLE 339 ENDO-FLEX GMBH: COMPANY OVERVIEW 294 TABLE 340 ACE MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW 295 TABLE 341 MEDI-GLOBE GMBH: COMPANY OVERVIEW 295 TABLE 342 MEDORAH MEDITEK PVT. LTD.: COMPANY OVERVIEW 296 TABLE 343 INNERMEDICAL CO., LTD.: COMPANY OVERVIEW 297 _ FIGURE 1 ENDOSCOPIC ULTRASOUND MARKET: MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD 30 FIGURE 2 ENDOSCOPIC ULTRASOUND MARKET: YEARS CONSIDERED 31 FIGURE 3 ENDOSCOPIC ULTRASOUND MARKET: RESEARCH DESIGN 33 FIGURE 4 ENDOSCOPIC ULTRASOUND MARKET: KEY DATA FROM SECONDARY SOURCES 35 FIGURE 5 ENDOSCOPIC ULTRASOUND MARKET: KEY PRIMARY SOURCES 36 FIGURE 6 ENDOSCOPIC ULTRASOUND MARKET: KEY DATA FROM PRIMARY SOURCES 37 FIGURE 7 ENDOSCOPIC ULTRASOUND MARKET: KEY INSIGHTS FROM PRIMARIES 38 FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND OTHER PARTICIPANTS 38 FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 39 FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 39 FIGURE 11 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 40 FIGURE 12 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION (2023) 41 FIGURE 13 ENDOSCOPIC ULTRASOUND MARKET: TOP-DOWN APPROACH 41 FIGURE 14 ENDOSCOPIC ULTRASOUND MARKET: SUPPLY-SIDE ANALYSIS (2023) 43 FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44 FIGURE 16 ENDOSCOPIC ULTRASOUND MARKET: CAGR PROJECTIONS 45 FIGURE 17 ENDOSCOPIC ULTRASOUND MARKET: DATA TRIANGULATION 46 FIGURE 18 ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 49 FIGURE 19 ENDOSCOPIC ULTRASOUND MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 50 FIGURE 20 ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 50 FIGURE 21 ENDOSCOPIC ULTRASOUND MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 51 FIGURE 22 GEOGRAPHICAL SNAPSHOT OF ENDOSCOPIC ULTRASOUND MARKET 52 FIGURE 23 RISING PREVALENCE OF CANCER AND INCREASING POPULARITY OF MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET 53 FIGURE 24 CHINA AND HOSPITALS SEGMENTS COMMANDED LARGEST SHARE IN ASIA PACIFIC ENDOSCOPIC ULTRASOUND MARKET IN 2023 54 FIGURE 25 JAPAN TO WITNESS HIGHEST GROWTH RATE FROM 2024 TO 2029 55 FIGURE 26 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 56 FIGURE 27 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 56 FIGURE 28 ENDOSCOPIC ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57 FIGURE 29 SHARE OF SURGEONS PERFORMING OVER 100 ENDOSCOPIC PROCEDURES PER YEAR GLOBALLY, BY REGION (2024) 58 FIGURE 30 NUMBER OF ANNUAL PLANNED SESSIONS PER INDIVIDUAL IN UK (2021) 59 FIGURE 31 ENDOSCOPIC ULTRASOUND MARKET: VALUE CHAIN ANALYSIS 67 FIGURE 32 ENDOSCOPIC ULTRASOUND MARKET: SUPPLY CHAIN ANALYSIS 69 FIGURE 33 ENDOSCOPIC ULTRASOUND MARKET: PORTER’S FIVE FORCES ANALYSIS 71 FIGURE 34 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 73 FIGURE 35 KEY BUYING CRITERIA FOR TOP THREE END USERS 74 FIGURE 36 AVERAGE SELLING PRICE OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY TYPE (2023) 80 FIGURE 37 ENDOSCOPIC ULTRASOUND MARKET: ECOSYSTEM ANALYSIS 82 FIGURE 38 ENDOSCOPIC ULTRASOUND MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–DECEMBER 2024) 84 FIGURE 39 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR ENDOSCOPIC ULTRASOUND PATENTS (JANUARY 2014–DECEMBER 2024) 85 FIGURE 40 TOP APPLICANT COUNTRIES/REGIONS FOR ENDOSCOPIC ULTRASOUND PATENTS (JANUARY 2014–DECEMBER 2024) 86 FIGURE 41 ENDOSCOPIC ULTRASOUND MARKET: IMPACT OF AI/GEN AI 91 FIGURE 42 ENDOSCOPIC ULTRASOUND MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 93 FIGURE 43 ENDOSCOPIC ULTRASOUND MARKET: ADJACENT MARKETS 94 FIGURE 44 ENDOSCOPIC ULTRASOUND MARKET: INVESTMENT/VENTURE CAPITAL SCENARIO (2019–2024) 94 FIGURE 45 ENDOSCOPIC ULTRASOUND MARKET REGIONAL SNAPSHOT 134 FIGURE 46 NORTH AMERICA: ENDOSCOPIC ULTRASOUND MARKET SNAPSHOT 136 FIGURE 47 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET SNAPSHOT 172 FIGURE 49 MARKET SHARE ANALYSIS OF PLAYERS IN ENDOSCOPIC ULTRASOUND MARKET (2023) 224 FIGURE 50 ENDOSCOPIC ULTRASOUND MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 227 FIGURE 51 ENDOSCOPIC ULTRASOUND MARKET: COMPANY FOOTPRINT 228 FIGURE 52 ENDOSCOPIC ULTRASOUND MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 236 FIGURE 53 EV/EBITDA OF KEY VENDORS 239 FIGURE 54 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 239 FIGURE 55 ENDOSCOPIC ULTRASOUND MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 240 FIGURE 56 ENDOSCOPIC ULTRASOUND MARKET: R&D ASSESSMENT OF KEY PLAYERS (2021–2023) 241 FIGURE 57 OLYMPUS CORPORATION: COMPANY SNAPSHOT 247 FIGURE 58 MEDTRONIC: COMPANY SNAPSHOT 254 FIGURE 59 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 258 FIGURE 60 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 264 FIGURE 61 STERIS: COMPANY SNAPSHOT 272 FIGURE 62 CONMED CORPORATION: COMPANY SNAPSHOT 276 FIGURE 63 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT 278 FIGURE 64 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT 281

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們